Author:
Ding Xiaoxu,Cui Xiangguo,Cui Xiao,Wang Sai
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference26 articles.
1. Tang LL, Chen YP, Mao YP, Wang ZX, Guo R, Chen L, et al. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era. J Natl Compr Canc Netw. 2017;15:913-919.
2. Lee AW, Foo W, Law SC, Poon YF, Sze WM, O SK, et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J. 1997;3:355-361.
3. Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology;Pfister;J Natl Compr Canc Netw,2020
4. Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014;110:172-181.
5. Thyroid V40 predicts primary hypothyroidism after intensity modulated radiation therapy for nasopharyngeal carcinoma;Sommat;Int J Radiat Oncol Biol Phys,2017